NCT00430781 2015-05-08Pazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical CancerGlaxoSmithKlinePhase 2 Completed228 enrolled 21 charts